Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Cell Harvesting - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Cell Harvesting Market to Reach $359.2 Million by 2026
The global market for Cell Harvesting estimated at US$233.2 Million in the year 2020, is projected to reach a revised size of US$359.2 Million by 2026, growing at a CAGR of 7.3% over the analysis period.
Cell harvesting is a next-generation technique that involves collection of stem cells from the culture media for R&D and therapeutic applications. Growth in the global market is spurred by of increasing investments in clinical, cell-based and regenerative medicine research.
The technique is likely to gain from rising incidence of infectious and chronic diseases coupled with continuous expansion of the biotechnology and biopharmaceutical industries. Stem cell research is estimated to witness fastest growth as stem cells derived from the bone marrow hold potential to advance stem cell biology, regenerative medicine and stem cell-based therapies.
Stem cells are one of the latest entrants joining the race for COVID-19 cure. The therapy involves intravenous administration of MSCs derived from the human placenta to COVID-19 patients for boosting the immune response and helping the body in fighting the infection. The approach is being investigated by various researchers in the US and China, with some of them observing positive outcomes.
Manual, one of the segments analyzed in the report, is projected to record 7.9% CAGR and reach US$284.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Automated segment is readjusted to a revised 5.6% CAGR for the next 7-year period. The Manual segment dominates market share owing to extensive adoption of these systems as a result of their affordable and user-friendly nature.
The U.S. Market is Estimated at $78.8 Million in 2021, While China is Forecast to Reach $32.1 Million by 2026
The Cell Harvesting market in the U.S. is estimated at US$78.8 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$32.1 Million by the year 2026 trailing a CAGR of 10.4% over the analysis period.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR. The US dominates market share due to increasing R&D investments and favorable government policies.
The US FDA has approved cord blood-based blood-forming stem cells for use in the US. These cells along with stem cells derived from the bone marrow are widely used in medical transplant procedures for treatment of cancer along with diseases related to the immune system and blood.
The Asia-Pacific market expansion is being driven by increasing R&D spending to develop new treatments, government policies favoring stem cell research, and public-private efforts to foster stem cell-based treatments.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Cell Harvesting - A Prelude
- With Stem Cells Holding Potential to Emerge as Savior for Healthcare System Struggling with COVID-19 Crisis, Demand for Cell Harvesting to Grow
- Select Clinical Trials in Progress for MSCs in the Treatment of COVID-19
- Lack of Antiviral Therapy Brings Spotlight on MSCs as Potential Option to Treat Severe Cases of COVID-19
- Stem Cells Garner Significant Attention amid COVID-19 Crisis
- Growing R&D Investments & Rising Incidence of Chronic Diseases to Drive the Global Cell Harvesting Market over the Long-term
- US Dominates the Global Market, Asia-Pacific to Experience Lucrative Growth Rate
- Biopharmaceutical & Biotechnology Firms to Remain Key End-User
- Remarkable Progress in Stem Cell Research Unleashes Unlimited Avenues for Regenerative Medicine and Drug Development
- Drug Development
- Therapeutic Potential
- A Prelude to Genetic Testing
2. FOCUS ON SELECT PLAYERS (Total 30 Featured)
- ADS Biotec Inc.
- Argos Technologies Inc.
- Arthrex, Inc.
- Avita Medical
- Bertin Bioreagent
- BRAND GMBH + CO KG
- Biomedical Research & Development Laboratories Inc. (Brandel)
- (USA)
- Connectorate AG
- Cox Scientific Ltd
- PerkinElmer Inc.
- SP Industries
- Terumo BCT Inc.
- TOMTEC Imaging Systems GmbH
3. MARKET TRENDS & DRIVERS
- Development of Regenerative Medicine Accelerates Demand for Cell Harvesting
- The Use of Mesenchymal Stem Cells in Regenerative Medicine to Drive the Cell Harvesting Market
- Rise in Volume of Orthopedic Procedures Boosts Prospects for Stem Cell, Driving the Cell Harvesting
- Increasing Demand for Stem Cell Based Bone Grafts: Promising Growth Ahead for Cell Harvesting
- Spectacular Advances in Stem Cell R&D Open New Horizons for Regenerative Medicine
- Stem Cell Transplants Drive the Demand for Cell Harvesting
- Rise in Number of Hematopoietic Stem Cell Transplantation Procedures Propels Market Expansion
- Growing Incidence of Chronic Diseases to Boost the Demand for Cell Harvesting
- Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
- Ageing Demographics to Drive Demand for Stem Cell Banking
- Global Aging Population Statistics - Opportunity Indicators
- High Cell Density as Major Bottleneck Leads to Innovative Cell Harvesting Methods
- Advanced Harvesting Systems to Overcome Centrifugation Issues
- Sophisticated Filters for Filtration Challenges
- Innovations in Closed Systems Boost Efficiency & Productivity of Cell Harvesting
- Enhanced Harvesting and Separation of Micro-Carrier Beads
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
UNITED STATES
- Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022
- Increasing Research on Stem Cells for Treating COVID-19 to drive the Cell Harvesting Market
- Rising Investments in Stem Cell-based Research Favors Cell Harvesting Market
- A Strong Regenerative Medicine Market Drives Cell Harvesting Demand
- Arthritis
- Percentage of Population Diagnosed with Arthritis by Age Group
- Rapidly Ageing Population: A Major Driving Demand for Cell Harvesting Market
- Increasing Incidence of Chronic Diseases Drives Focus onto Cell Harvesting
- CVD in the US: Cardiovascular Disease* Prevalence in Adults by Gender & Age Group
- Rising Cancer Cases Spur Growth in Cell Harvesting Market
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/j6gnlu
Attachment
